Australia markets close in 2 hours 27 minutes

Genetic Technologies Limited (GTG.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.00800.0000 (0.00%)
As of 10:55AM AEDT. Market open.

Genetic Technologies Limited

60-66 Hanover Street
Fitzroy, VIC 3065
Australia
61 3 8412 7000
http://www.gtglabs.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. Jerzy MuchnickiInterim CEO & Exec. Director153.11kN/A1957
Mr. Phillip Hains C.A., M.B.A., B Bus, CA, MBAChief Financial OfficerN/AN/A1961
Mr. Stanley SackChief Operating Officer318.28kN/A1964
Dr. Richard AllmanScientific Director188.21kN/A1960
Mr. Paul Keith Mathieson Viney B. Bus, FCPA, FGIA, FCIConsultantN/AN/AN/A
Mr. Justyn StedwellCompany Sec.N/AN/A1981
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage patient's health in Australia and the United States. It engages in the development of various cancer risk assessment tests under the GeneType name. The company's lead products are GeneType for breast cancer for non-hereditary breast cancer, and GeneType for colorectal cancer. It also offers BREVAGenplus tests. The company sells its products through online health platform. It has research and collaboration agreements with the University of Melbourne, the Translational Genomics Research Institute, Memorial Sloan Kettering, the Ohio State University, and Harvard Nurses' Health Study. Genetic Technologies Limited was incorporated in 1987 and is based in Fitzroy, Australia.

Corporate governance

Genetic Technologies Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.